BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 2619361)

  • 1. Antileishmanial effects of clofazimine and other antimycobacterial agents.
    Evans AT; Croft SL; Peters W; Neal RA
    Ann Trop Med Parasitol; 1989 Oct; 83(5):447-54. PubMed ID: 2619361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The activity of plumbagin and other electron carriers against Leishmania donovani and Leishmania mexicana amazonensis.
    Croft SL; Evans AT; Neal RA
    Ann Trop Med Parasitol; 1985 Dec; 79(6):651-3. PubMed ID: 3834847
    [No Abstract]   [Full Text] [Related]  

  • 3. The activity of nitrofurazone and furazolidone against Leishmania donovani, L. major and L. enriettii in vitro and in vivo.
    Neal RA; van Bueren J; Hooper G
    Ann Trop Med Parasitol; 1988 Oct; 82(5):453-6. PubMed ID: 2855778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the in vitro and in vivo antileishmanial activity of a chloroquinolin derivative against Leishmania species capable of causing tegumentary and visceral leishmaniasis.
    Soyer TG; Mendonça DVC; Tavares GSV; Lage DP; Dias DS; Ribeiro PAF; Perin L; Ludolf F; Coelho VTS; Ferreira ACG; Neves PHAS; Matos GF; Chávez-Fumagalli MA; Coimbra ES; Pereira GR; Coelho EAF; Antinarelli LMR
    Exp Parasitol; 2019 Apr; 199():30-37. PubMed ID: 30817917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of new N-benzyl-1H-benzimidazol-2-amine derivatives against cutaneous, mucocutaneous and visceral Leishmania species.
    Nieto-Meneses R; Castillo R; Hernández-Campos A; Maldonado-Rangel A; Matius-Ruiz JB; Trejo-Soto PJ; Nogueda-Torres B; Dea-Ayuela MA; Bolás-Fernández F; Méndez-Cuesta C; Yépez-Mulia L
    Exp Parasitol; 2018 Jan; 184():82-89. PubMed ID: 29191699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and pharmacological evaluation of mono-arylimidamides as antileishmanial agents.
    Zhu X; Farahat AA; Mattamana M; Joice A; Pandharkar T; Holt E; Banerjee M; Gragg JL; Hu L; Kumar A; Yang S; Wang MZ; Boykin DW; Werbovetz KA
    Bioorg Med Chem Lett; 2016 May; 26(10):2551-2556. PubMed ID: 27048943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Herbicides to curb human parasitic infections: in vitro and in vivo effects of trifluralin on the trypanosomatid protozoans.
    Chan MM; Grogl M; Chen CC; Bienen EJ; Fong D
    Proc Natl Acad Sci U S A; 1993 Jun; 90(12):5657-61. PubMed ID: 8516314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antileishmanial activity of a series of N²,N⁴-disubstituted quinazoline-2,4-diamines.
    Van Horn KS; Zhu X; Pandharkar T; Yang S; Vesely B; Vanaerschot M; Dujardin JC; Rijal S; Kyle DE; Wang MZ; Werbovetz KA; Manetsch R
    J Med Chem; 2014 Jun; 57(12):5141-56. PubMed ID: 24874647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3'-Deoxy-3'-fluoroinosine as a potent antileishmanial agent. The metabolism and selective cytotoxic effect of 3'-deoxy-3'-fluoroinosine against Leishmania tropica and L. donovani in vitro and in vivo.
    Shin IS; Tanifuji H; Arata Y; Morizawa Y; Nakayama T; Wataya Y
    Parasitol Res; 1995; 81(7):622-6. PubMed ID: 7479655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydrazide antidepressants possess novel antileishmanial activity in vitro and in vivo.
    Evans AT; Croft SL; Peters W; Neal RA
    Ann Trop Med Parasitol; 1989 Feb; 83(1):19-24. PubMed ID: 2596901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leishmanicidal activity of the Agaricus blazei Murill in different Leishmania species.
    Valadares DG; Duarte MC; Oliveira JS; Chávez-Fumagalli MA; Martins VT; Costa LE; Leite JP; Santoro MM; Régis WC; Tavares CA; Coelho EA
    Parasitol Int; 2011 Dec; 60(4):357-63. PubMed ID: 21723957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical treatment of New and Old World cutaneous leishmaniasis in experimental animals.
    el-On J; Hamburger AD
    Trans R Soc Trop Med Hyg; 1987; 81(5):734-7. PubMed ID: 3449988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo prophylactic and curative activity of the triterpene saponin PX-6518 against cutaneous Leishmania species.
    Inocêncio da Luz RA; Vermeersch M; Deschacht M; Hendrickx S; Van Assche T; Cos P; Maes L
    J Antimicrob Chemother; 2011 Feb; 66(2):350-3. PubMed ID: 21131319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of antileishmanial activities of Tio2@Ag nanoparticles on biological properties of L. tropica and L. infantum parasites, in vitro.
    Allahverdiyev AM; Abamor ES; Bagirova M; Baydar SY; Ates SC; Kaya F; Kaya C; Rafailovich M
    Exp Parasitol; 2013 Sep; 135(1):55-63. PubMed ID: 23792003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacies of KY62 against Leishmania amazonensis and Leishmania donovani in experimental murine cutaneous leishmaniasis and visceral leishmaniasis.
    Al-Abdely HM; Graybill JR; Bocanegra R; Najvar L; Montalbo E; Regen SL; Melby PC
    Antimicrob Agents Chemother; 1998 Oct; 42(10):2542-8. PubMed ID: 9756753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo antileishmanial activity of a fluoroquinoline derivate against Leishmania infantum and Leishmania amazonensis species.
    Tavares GSV; Mendonça DVC; Lage DP; Antinarelli LMR; Soyer TG; Senna AJS; Matos GF; Dias DS; Ribeiro PAF; Batista JPT; Poletto JM; Brandão GC; Chávez-Fumagalli MA; Pereira GR; Coimbra ES; Coelho EAF
    Acta Trop; 2019 Mar; 191():29-37. PubMed ID: 30586571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigen recognition by effector T cells in antileishmanial defense.
    Sypek JP; Panosian CB; Wyler DJ
    J Infect Dis; 1985 Nov; 152(5):1057-63. PubMed ID: 2413143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SQ109 inhibits proliferation of Leishmania donovani by disruption of intracellular Ca
    Gil Z; Martinez-Sotillo N; Pinto-Martinez A; Mejias F; Martinez JC; Galindo I; Oldfield E; Benaim G
    Parasitol Res; 2020 Feb; 119(2):649-657. PubMed ID: 31897791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An effective in vitro and in vivo antileishmanial activity and mechanism of action of 8-hydroxyquinoline against Leishmania species causing visceral and tegumentary leishmaniasis.
    Costa Duarte M; dos Reis Lage LM; Lage DP; Mesquita JT; Salles BC; Lavorato SN; Menezes-Souza D; Roatt BM; Alves RJ; Tavares CA; Tempone AG; Coelho EA
    Vet Parasitol; 2016 Feb; 217():81-8. PubMed ID: 26827866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The sensitivity of Leishmania species to aminosidine.
    Neal RA; Allen S; McCoy N; Olliaro P; Croft SL
    J Antimicrob Chemother; 1995 May; 35(5):577-84. PubMed ID: 7592170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.